Spectrum Vascular ("Spectrum" or the "Company"), a provider of vascular access and medication management products designed to reduce health care-acquired infections, announced today a strategic ...
Gene therapy maker bluebird to go private in discounted deal amid cash crunch Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital Partners at a ...
Hosted on MSN1mon
Bluebird Bio to Be Acquired by Carlyle Group, SK CapitalCash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback